A Phase II Trial of Multiple Cycles of Sequential High Dose Chemotherapy for Patients With Chemotherapy Sensitive Relapsed Non-Hodgkin's Lymphoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cyclophosphamide; Cytarabine; Etoposide; Melphalan; Mitoxantrone; Paclitaxel
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 17 Apr 2013 Biomarkers information updated
- 01 Sep 2009 Actual end date (Aug 2001) added as reported by ClinicalTrials.gov.
- 01 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.